SCHEMBL5744573

SCHEMBL5744573

Cc1ccc(COc2cccc(CC(C)C)c2C#N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
GRM2 Q14416 1/20 0.42
ALDH1A1 P00352 3/20 0.42
SGMS2 Q8NHU3 2/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CARM1 Q86X55 2/20 0.41
PRMT1 Q99873 2/20 0.41
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SLC1A5 Q15758 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5743196 0.85 NPC1 (0.46) NPC1RAB9AGRM2ALDH1A1SGMS2
SCHEMBL5741028 0.83 NPC1 (0.51) NPC1RAB9AALDH1A1SGMS2LMNA
SCHEMBL12585107 0.82 CARM1 (0.53) ALDH1A1SGMS2LMNACYP1A2CYP2C9
SCHEMBL23712420 0.79 MCL1 (0.50) NPC1RAB9AALDH1A1LMNAMAPT
SCHEMBL1154479 0.78 NPC1 (0.55) NPC1RAB9AALDH1A1SGMS2LMNA
SCHEMBL23434853 0.77 MAOB (0.50) NPC1RAB9AGRM2ALDH1A1CARM1
SCHEMBL5741700 0.74 SLC1A5 (0.47) RAB9AALDH1A1LMNACARM1PRMT1
SCHEMBL23046957 0.70 HTR1A (0.61) RAB9AALDH1A1LMNAMAPTMAPK1
SCHEMBL5741190 0.70 NPC1 (0.62) NPC1RAB9AGRM2ALDH1A1SGMS2
SCHEMBL13881659 0.69 CARM1 (0.54) NPC1RAB9AALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678146-A1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2006-07-12 EP disclosed
WO-2005040133-A1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-05-06 WO disclosed